Page 27 - Imperial College - Science for Humanity
P. 27

Imperial Global                                                  Equitable vaccine



                                                                  access and

                                                                  development



                                                                  Nearly one in five infants across the world does
                                                                  not have access to vaccines, and almost one third
                                                                  of deaths among children under five could be
 Greater global collaboration to meet global grand challenges     prevented through the use of vaccines. Imperial
                                                                  is leading two major vaccine manufacturing hubs
 Imperial Global                                                  to develop new technologies that can be quickly,
                                                                  easily and affordably manufactured in the places
                                                                  most vulnerable to infectious disease.

 Our goal: We will be a convenor, collaborator and   activity profiles that build on existing partnerships   The Chanjo Hub is an African-led collaboration
 partner of choice to facilitate the flow of ideas, talent   and local needs and opportunities.  designed to catalyze local research and
 and innovation to tackle grand global challenges.                innovation ecosystems in Kenya and Ghana
    Imperial Global Singapore is a new presence                   in order to deliver vaccines for endemic and
 Now: We are proud to be one of the world's most   on Singapore’s CREATE campus initially exploring    epidemic diseases in the region. The Future
 international universities. Our global collaborations,   the cyber security of medical devices. It will allow    Vaccine Manufacturing Research Hub is focused
 discoveries and networks are transforming lives and   us to develop significant new research and translation   on disruptive technology that allows developing
 creating opportunity in the UK and around the world.   programmes with partners across South East    countries to produce tailored vaccines within 100
 Our global community brings people together to   Asia, and support recruitment and career   days of an identified outbreak or threat. Novel
 contribute diverse perspectives, new ideas and fresh   development activities.  manufacturing programmes are currently being
 approaches to solving complex problems. Our global               developed with partners in Vietnam, Bangladesh
 network of alumni, friends and collaborators amplify   Imperial Global Ghana builds on established   and South Africa.
 our reach and impact.  partnerships in medical diagnostics, sustainable
    cities and entrepreneurship training. It will be a
 International collaboration is in Imperial’s DNA    knowledge hub that develops major programmes
 and at the core of our research: our academics have   across West Africa to increase the number, quality
 forged research collaborations in over 190 countries.   and impact of equitable STEMB partnerships with   “There is a critical need for local
 We enjoy strong bilateral research partnerships   African stakeholders. It underlines our commitment
 with universities and institutes including Technical   to building long-term, equitable partnerships   capacity to rapidly respond to
 University of Munich, Nanyang Technological   on the Continent.  known and unknown threats in
 University, Massachusetts Institute of Technology,
 African Institute for Mathematical Sciences, Indian   Imperial Global USA will strengthen our research   key areas like infectious disease.
 Institute of Science Bangalore, Tsinghua University   partnerships with US academic and industrial   The Imperial Global network
 and Centre National de la Recherche Scientifique.  partners and support our growing US alumni network
    and student recruitment opportunities.  will bring us closer to the people,
 Next: Imperial Global will bring even more of our      partners and potential solutions.
 work to the world, and more of the world to our work,   Imperial Global India will build Imperial’s profile
 amplifying our impact through a network of hubs in   and partnerships in an emerging scientific and   This includes the critical area
 strategic global cities. This network will demonstrate   industrial superpower. The hub will strengthen    Right: Professor Robin Shattock, Chair in Mucosal Infection and Immunity   of vaccine access where a
 our commitment to building long-term collaborations   the important UK-India knowledge bridge to
 with a diverse range of partners and stakeholders,   enable STEMB talent to drive forward research,   Ghana centre can support our
 foster new high-impact partnerships with industry,   education and innovation in key areas including    major Africa-led Chanjo Hub
 government and knowledge organisations, and    clean technology, fintech and biosciences.
 give us the opportunity to develop deeper links       to accelerate global access to
 with our alumni.  Imperial Global will enhance our academic   at the St Mary’s Hospital Campus.  vaccinations and treatments.”
 partnerships, access to talent, enterprise and
 Our first hubs will be in Singapore, Ghana, the USA   engagement. Most importantly, it will become
 and India. They will share characteristics that draw    a core part of our efforts to apply science for       Professor Faith Osier, Chair,
 on Imperial’s unique strengths but have different   the good of humanity.  Immunology and Vaccinology



 24                                                          25
   22   23   24   25   26   27   28   29   30   31   32